Publications by authors named "Andreas Fruend"

Background: Delirium is a frequent and serious complication of cardiac procedures that can lead to serious long-term health restrictions. As primary prevention is more effective in reducing rate of delirium than the therapy itself, this study aimed to investigate the effect of a multidisciplinary delirium prevention bundle on the postoperative delirium rate in patients undergoing cardiac procedures.

Methods: In this system-based quality improvement study, a four-component delirium prevention bundle was implemented in patients undergoing cardiac procedures at a single high-volume center.

View Article and Find Full Text PDF

Background: Aortic or mitral valvular regurgitation (left cardiac valvular regurgitation, LCVR) of less than second-degree (< degree II) occasionally found in competitive athletes is of questionable relevance. Precisely detectable by echocardiography there is scarce published data that clarifies cardiopulmonary capacity or any limitations LCVR < degree ll may cause.

Methods: In this single-centre study we consecutively recruited highly trained athletes (n= 14) with LCVR < degree ll detected in 2D echo.

View Article and Find Full Text PDF
Article Synopsis
  • Endurance athletes and power athletes show different cardiac adaptations, and little research has focused on older handball players' heart health.
  • A study involving 33 former elite handball players revealed that 30% had atrial fibrillation (AF), with significant differences in heart size and muscle thickness compared to healthy controls.
  • The findings suggest that team sports like handball, which include both endurance and static components, might increase the risk of AF in athletes over 50, highlighting the need for further research in non-endurance sports.
View Article and Find Full Text PDF

Background: Current guidelines concerning the treatment of patients with chronic congestive heart failure (CHF) include ergospirometry-directed dynamic exercises on a daily basis. Several prospective, randomized trials have confirmed its positive influence on clinical symptoms and prognosis of the disease. Patients with stable coronary artery disease (CAD) can benefit from a 27% reduction of mortality, as shown in meta-analyses of several studies.

View Article and Find Full Text PDF